Iridex Story

<div class='circular--portrait' style='background:#483D8B;color: #f2f2f2;font-size:4em;'>IC</div>
IRIX -- USA Stock  

USD 7.42  0.29  3.76%

Iridex Cp Asset Turnover is fairly stable at the moment as compared to the past year. Iridex Cp reported Asset Turnover of 0.94 in 2020. Debt to Equity Ratio is likely to rise to 0.26 in 2021, whereas Net Income Per Employee is likely to drop (90 K) in 2021. The basic goal of this article is to give investors our perspective on Iridex for April. We will forecast Iridex Cp value for investors.
Published over three weeks ago
View all stories for Iridex Cp | View All Stories
Estimating Iridex Cp (NASDAQ:IRIX) price for April 2021.
This firm has a beta of 0.3312. Let's try to break down what Iridex's beta means in this case. Iridex Cp returns are very sensitive to returns on the market. As the market goes up or down, Iridex Cp is expected to follow. The beta indicator helps investors understand whether Iridex Cp moves in the same direction as the rest of the market, and how volatile (i.e., risky) it is compared to the market (i.e., selected benchmark). In other words, if Iridex deviates very little from the market, it does not add much risk to the portfolio, but it also doesn't increase the expected returns.
There are currently many different techniques concerning forecasting the market as a whole as well as predicting future values of individual securities such as Iridex Cp. Regardless of method or technology, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.

Predictive Modules for Iridex Cp

Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Iridex Cp's stock price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Iridex Cp in the context of predictive analytics.
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Iridex Cp. Your research has to be compared to or analyzed against Iridex Cp's peers to derive any actionable benefits. When done correctly, Iridex Cp's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Iridex Cp.

How important is Iridex Cp's Liquidity

Iridex Cp financial leverage refers to using borrowed capital as a funding source to finance Iridex Cp ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Iridex Cp financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Please check the breakdown between Iridex Cp's total debt and its cash.

How Iridex utilizes its cash?

To perform a cash flow analysis of Iridex Cp, investors first need to understand how to read the cash flow statement. A cash flow statement shows the amount of cash Iridex Cp is receiving and how much cash it distributes out in a given period. The Iridex Cp cash flow statement breaks down these inflows and outflows into different buckets, including operating activities, investing activities, and financing activities.
Iridex Cp Net Cash Flow from Operations is fairly stable at the moment as compared to the past year. Iridex Cp reported Net Cash Flow from Operations of (3.24 Million) in 2020

Iridex Cp exotic insider transaction detected

Legal trades by Iridex Cp insiders are very common, as founders, directors, or employees of any publicly traded firm often have stock or stock options. These trades are made public in the United States through the filing of Form 4 of the Securities and Exchange Commission. Below entry was recorded recently and is publicly available as an insider trade:
Iridex insider trading alert for general transaction of common stock by Topcon America Corp, the corporate stakeholder, on 1st of April 2021. This event was filed by Iridex Corp with SEC on 2021-04-01. Initial filing of beneficial ownership - SEC Form 3 [view details]   
Note, although insider trading is legal, in the United States, Canada, Australia, and Germany, for mandatory reporting purposes, corporate insiders are defined as a company's officers, directors, and any beneficial owners of more than 10% of a class of the company's equity securities.

Breaking down the case for Iridex Cp

Iridex Cp is displaying above-average volatility over the selected time horizon. Investors should scrutinize Iridex Cp independently to ensure intended market timing strategies are aligned with expectations about Iridex Cp volatility. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Iridex Cp's stock risk against market volatility during both bullying and bearish trends. The higher level of volatility that comes with bear markets can directly impact Iridex Cp's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

Returns Breakdown

Return on Investment(8.74)
Return on Assets(0.25)
Return on Equity(0.31)
Return Capital(0.12)
Return on Sales(0.0563)

Iridex is expecting lower volatility in April

Semi variance is down to 22.93. It may suggest a possible volatility slide. Iridex Cp is displaying above-average volatility over the selected time horizon. Investors should scrutinize Iridex Cp independently to ensure intended market timing strategies are aligned with expectations about Iridex Cp volatility. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Iridex Cp's stock risk against market volatility during both bullying and bearish trends. The higher level of volatility that comes with bear markets can directly impact Iridex Cp's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

Our Final Take On Iridex Cp

While some other entities within the medical devices industry are still a little expensive, even after the recent corrections, Iridex Cp may offer a potential longer-term growth to investors. To conclude, as of the 22nd of March 2021, our concluding 30 days buy-hold-sell recommendation on the company is Hold. We believe Iridex Cp is fairly valued with very small chance of distress for the next two years.

About Contributor

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Vlad Skutelnik do not own shares of Iridex Cp. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com